Jupiter Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,500
Closed -$292K 88
2021
Q3
$292K Hold
2,500
0.14% 78
2021
Q2
$286K Hold
2,500
0.14% 78
2021
Q1
$277K Buy
+2,500
New +$267K 0.14% 75

Other funds holding ABBV

Jupiter Wealth Management's ABBV Position: Q4 2021 in Review

Jupiter Wealth Management sold out of AbbVie (ABBV) in Q4 2021, closing a stake of 2,500 shares — an estimated $292K sold.

Jupiter Wealth Management first reported a position in ABBV in Q1 2021 and held it in 3 quarters. The position peaked at $292K in Q3 2021. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

  • Jupiter Wealth Management reported no remaining AbbVie position as of Q4 2021 after selling out during the quarter.
  • Jupiter Wealth Management sold 2,500 AbbVie shares in Q4 2021, an estimated $292K.
  • Jupiter Wealth Management first reported a position in AbbVie in Q1 2021 and held it in 3 quarters.
  • Jupiter Wealth Management's AbbVie position peaked at $292K in Q3 2021.
  • 2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Jupiter Wealth Management's 13F filing for Q4 2021, filed 9 Feb 2022.